News about Global Pharma

Cariflex Inaugurates World's Largest Polyisoprene Latex Plant in Singapore

With an investment of USD 355 million, the plant is the largest of its kind in the world and will significantly expand Cariflex's production capacity to meet the growing demand for high-quality synthetic latex for medical and protective applications.

Global Pharma | 15/05/2025 | By Manvi |  473

Standard Glass Partners with Japan's AGI to Manufacture Glass-Lined Shell and Tube Heat Exchangers in India

Standard Glass Lining Technology (SGLTL) in collaboration with Japan’s AGI Group and its affiliate GL HAKKO will manufacture glass-lined shell and tube heat exchangers in India. The production is estimated to commence by Q4, FY26.

Global Pharma | 14/05/2025 | By Manvi |  761

Zydus Secures EIR from USFDA for Ambernath API Manufacturing Facility

Zydus Lifesciences has received an establishment inspection report (EIR) from the United States Food and Drug Administration (USFDA). The EIR has been classified under the no action indicated (NAI) category.

Global Pharma | 14/05/2025 | By Manvi |  430

USFDA Completes Inspection at Solara's Ambernath Facility with Zero Form 483 Observations

Solara Active Pharma Sciences Ltd. announced that its Ambernath API manufacturing facility has successfully completed a USFDA inspection with zero Form 483 observations, confirming the site’s compliance with regulatory standards.

Global Pharma | 14/05/2025 | By Manvi |  523

CuraTeQ Biologics Secures Approval for Biosimilar Zefylti from UK's MHRA

Aurobindo Pharma announced that its subsidiary CuraTeQ Biologics has received UK MHRA approval for Zefylti, a filgrastim biosimilar for treating neutropenia, marking its second MHRA-approved biosimilar.
<br />

Global Pharma | 14/05/2025 | By Manvi |  481

Caplin Steriles Receives USFDA Approval for Haloperidol Decanoate Injection

Caplin Steriles Ltd., a subsidiary of Caplin Point Ltd., gets an entry into the US market with the final approval from Abbreviated New Drug Application (ANDA) for Haloperidol Decanoate Injection.

Global Pharma | 14/05/2025 | By Manvi |  405

Terumo Neuro Launches SOFIA 88, Expanding Stroke Portfolio with Large-Bore Catheter

The launch builds on the proven clinical performance and global legacy of the SOFIA™ Catheter line, which has supported more than 500,000 procedures across 170 countries over the past decade.

Global Pharma | 13/05/2025 | By Manvi |  293

Eargo Unveils Eargo 8, First OTC Hearing Aid from Newly Formed LXE Hearing

Eargo, Inc., an LXE Hearing company on a mission to improve the quality of life of people with hearing loss, announced the launch of Eargo 8, its most advanced self-fitting over-the-counter (OTC) hearing aid yet.

Global Pharma | 13/05/2025 | By Manvi |  725

Collegium Pharmaceutical Buy Back USD 25 million in shares

Collegium maintains impressive gross profit margins of 87.04 percent and has achieved revenue growth of 17.17 percent over the last twelve months. This growth is attributed to strong sales in the company’s pain management portfolio and the ADHD medication Jornay PM.

Global Pharma | 13/05/2025 | By Manvi |  208

Colorcon and ASHA Cellulose Partner for Ethyl Cellulose Polymer Distribution

Colorcon and ASHA Cellulose have partnered to support the development and manufacture of barrier membrane formulations for the pharmaceutical and nutraceutical industries.

Global Pharma | 12/05/2025 | By Manvi |  418